Business

Issue of Equity

Issue of Equity.

articleFortis Frontier PlcMarch 25, 20224/company/fortis-frontier-plc/news/issue-of-equity-331
Issue of Equity

About this update from Fortis Frontier Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 9873F\n MyHealthChecked PLC\n 25 March 2022\n  \n \n \n \n MyHealthChecked plc\n \n \n (\n \"\n MyHealthChecked\n \"\n or \n \"\n the Company\n \"\n )\n \n \n  \n \n \n Issue of Equity\n \n \n Performance related deferred consideration to be satisfied in full\n \n \n  \n \n \n MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company,\n announces that \n a deferred consideration of £0.24m, payable in shares, has been made in relation to the acquisition of The Genome Store Ltd (\"The Genome Store\"), after all performance milestones were met.\n \n \n  \n \n \n The Genome Store, a provider of home-administered postal genomic test services, was acquired by MyHealthChecked in November 2020, and the deferred consideration was conditional upon the achievement of revenue targets along with other operational criteria including new product development targets. \n \n \n  \n \n \n The deferred consideration will be satisfied by the issue of 24 million new ordinary shares of 0.1p each (\"New Ordinary Shares\") in the capital of the Company at an issue price of 1p per share.\n \n \n  \n \n \n Admission of the New Ordinary Shares to trading on AIM and Total Voting Rights\n \n \n The New Ordinary Shares have been allotted and application will be made for their admission to trading (\"Admission\") on the AIM Market of the London Stock Exchange. Admission is expected to take place on or around 30 March 2022.\n \n \n  \n \n \n The New Ordinary Shares will, when issued, be credited as fully paid and will rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid after Admission.\n \n \n  \n \n \n For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules (\"DTRs\"), the issued ordinary share capital of the Company following Admission will consist of 780,088,967 Ordinary Shares with voting rights attached (one vote per Ordinary Share). There are no Ordinary Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.\n \n \...

More updates from Fortis Frontier Plc